Active not recruitingOBSERVATIONAL

Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments

This study focuses on a skin condition called botriomycoma, which can sometimes grow near the central line in children who receive their nutrition directly into their bloodstream at home. Although these growths are usually harmless, they can cause issues like infections or blockages, which could be serious for children who rely on their central line for a long time. The study wants to discover more about why these growths develop, what makes certain children more likely to get them, and which treatments work best. This initial research will help doctors better understand and manage this condition, aiming to improve the health and well-being of children needing long-term central line care.

At a glance

Status

Active not recruiting

Sponsor

Hospices Civils de Lyon

Enrolment target

240

Start

01 Apr 2022

Estimated completion

03 Mar 2025

Home Parenteral Nutrition Intestinal Failure Central Line Botriomycoma Infection Sepsis Antibiotics

What is this study about?

This study is about a kind of skin growth called a botriomycoma. These growths are typically harmless and not cancerous, but they can sometimes pop up near the central line, which is a tube placed into a large vein to give children special nutrition (called parenteral nutrition) directly into their bloodstream at home. For children who rely on these lines for a long time, these growths can cause problems, such as making it harder for doctors or parents to access the line properly, or even leading to serious infections like sepsis.

While doctors know about these growths, not much research has been done to understand them fully. This study is a first step to change that. It aims to gather information about children who have had a botriomycoma near their central line. We want to find out if there are particular reasons some children develop them, such as other health conditions or how long they've had their central line.

The study will also look at the different ways these growths have been treated in the past and how successful those treatments were. By understanding these factors better, doctors hope to find improved ways to prevent botriomycomas from forming and to treat them effectively when they do appear. This research is important because it could help reduce the risk of infections and other complications for children who depend on central lines for their health.

Key takeaways

The study explores skin growths (botriomycomas) at central line sites in children.
It aims to identify why these growths happen and what treatments work best.
This research focuses on children who receive special nutrition at home through a central line.
Participation involves reviewing past medical records only; no direct patient involvement.
The findings could help improve care and reduce central line complications for children.

Who may be eligible?

This study is looking for information from medical records of children and young people up to 18 years old who are receiving all their nutrition through a central line at home. An important part of being considered for this study is that they must have been diagnosed with a botriomycoma near their central line at some point.

However, some children would not be included. For example, if the botriomycoma was diagnosed more than 10 years ago and there isn't enough information in their medical notes from that time. Also, if a patient is over 18 years old or if they don't receive their nutrition through a central line at home, they wouldn't be part of this particular study. The study focuses specifically on children who rely on home parenteral nutrition.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Is your child 18 years old or younger?
Does your child currently receive their nutrition through a central line at home?
Has your child ever been diagnosed with a botriomycoma near their central line?
Was the botriomycoma diagnosed within the last 10 years (and not older than that)?
Has your child never been diagnosed with a botriomycoma on their central line?

Answer every question to see your result.

What does participation involve?

This study is a "pilot study," which means it's an initial investigation. It's collecting information from existing medical records, so you or your child won't need to do anything extra. There are no special visits, tests, or medication involved for patients. Your medical team will simply review your child's past health information relating to their central line and any botriomycomas to help the researchers understand the condition better. The study does not involve direct contact with patients or any changes to their current care plan; it simply uses data that has already been recorded during routine medical care.

Potential risks and benefits

Since this study only involves looking at existing medical records, there are no direct physical risks or inconveniences for you or your child. The benefit is that the information gathered will help doctors better understand botriomycomas in children with central lines, potentially leading to improved prevention and treatment in the future. All personal information will be kept confidential. You have the right to ask questions about the study and can withdraw your permission for your child's anonymised data to be used at any time without affecting their care.

Locations (1)

Hôpital Mère-Enfant
Verified postcode
Bron, France

Common questions

What is a central line?

A central line is a special tube inserted into a large vein, usually in the chest or arm, to deliver medicines or nutrients directly into the bloodstream over a long period.

What is a botriomycoma?

It's a common, non-cancerous skin growth that can sometimes appear, often looking like a small red lump, and can develop near the opening where the central line enters the body.

Does this study involve my child taking new medication?

No, this study only reviews existing medical records. Your child will not be asked to take any new medication or have any extra procedures.

Will my child's name be used in the study?

No, all information collected from medical records will be kept private and anonymous, meaning your child's name or other identifying details will not be used.

Why is this study important?

It's important because it will help doctors learn more about these growths, which could lead to better ways to prevent and treat them, improving care for children with central lines.